Drug intelligence / Profile preview

JenaMos

Development stage: Unknown
Lead developer: Jena Herbals
Administration: Topical

Overview

JenaMos is an herbal mosquito repellent developed and manufactured by Jena Herbals Limited, a Ugandan company founded by Professor Patrick Ogwang. The product is formulated from indigenous plant extracts and is intended for topical application to the skin to deter mosquitoes. By preventing bites, JenaMos serves as a prophylactic tool against mosquito-borne diseases such as malaria, dengue, and Zika virus. It is officially approved by the Uganda National Drug Authority (NDA) as a finished herbal medicinal product, reflecting its status as a commercially available health product in the Ugandan market.

Brand names: JenaMos
Other names: Jena Mos

Beyond the preview

Go deeper on JenaMos.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JenaMos.

Explore the full profile